A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19
Clinical trial NCT07222384 · COMPLETED
Trial details
- NCT number
- NCT07222384
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-30
- Primary completion
- 2026-07-24
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.